Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.

Novartis Pharmaceuticals Corporation, USCDMA, One Health Plaza, East Hanover, NJ 07936-1080, USA.
Gut (Impact Factor: 13.32). 11/2004; 53(10):1452-8. DOI: 10.1136/gut.2003.035451
Source: PubMed

ABSTRACT Serotonin (5-hydroxtryptamine, 5-HT) is an important factor in gut function, playing key roles in intestinal peristalsis and secretion, and in sensory signalling in the brain-gut axis. Removal from its sites of action is mediated by a specific protein called the serotonin reuptake transporter (SERT or 5-HTT). Polymorphisms in the promoter region of the SERT gene have effects on transcriptional activity, resulting in altered 5-HT reuptake efficiency. It has been speculated that such functional polymorphisms may underlie disturbance in gut function in individuals suffering with disorders such as irritable bowel syndrome (IBS). The aim of this study was to assess the potential association between SERT polymorphisms and the diarrhoea predominant IBS (dIBS) phenotype.
A total of 194 North American Caucasian female dIBS patients and 448 female Caucasian controls were subjected to genotyping.
Leucocyte DNA of all subjects was analysed by polymerase chain reaction based technologies for nine SERT polymorphisms, including the insertion/deletion polymorphism in the promoter (SERT-P) and the variable tandem repeat in intron 2. Statistical analysis was performed to assess association of any SERT polymorphism allele with the dIBS phenotype.
A strong genotypic association was observed between the SERT-P deletion/deletion genotype and the dIBS phenotype (p = 3.07x10(-5); n = 194). None of the other polymorphisms analysed was significantly associated with the presence of disease.
Significant association was observed between dIBS and the SERT-P deletion/deletion genotype, suggesting that the serotonin transporter is a potential candidate gene for dIBS in women.

Download full-text


Available from: David Alpers, Sep 16, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: D+ (high digestion efficiency) and D- (low digestion efficiency) genetic chicken lines selected for divergent digestion efficiency were compared in this experiment. Gizzard functions were tested in terms of digesta mean retention time and reactions to high dilution of a corn diet with 15% coarse sunflower hulls. The corn standard (S) and high fibre (F) experimental diets were given from 9 days of age to chickens from both lines. Besides the measurements of growth efficiencies (9 to 20 days), digestibilities (20 to 23 days) and gut anatomy (0, 9, 29, 42 and 63 days), two digestive transit studies were performed at 9 and 29 days of age. For the transit studies, the S and F diets were labelled with 0.5% TiO2 and 1% Cr-mordanted sunflower hulls. These diets were fed ad libitum during 3 days, and then the birds were euthanized. The digestive contents were analysed for the determination of marker concentrations and mean retention times (MRTs) in digestive compartments (crop + oesophagus, proventriculus + gizzard, duodenum + jejunum, ileum, rectum + cloaca and caeca) were determined. D+ birds were confirmed as better digesters than D- birds during the growth period, in association with larger gizzard and pancreas, and lighter small intestine in D+ than in D-birds. The MRT in the proventriculus-gizzard system, higher in D+ than in D- birds, was a major factor associated with differences between D+ and D- birds regarding digestion efficiencies and gut anatomy. Diet dilution with fibres reduced differences in digestion efficiencies and proventriculus-gizzard MRT between lines. Differences in gut anatomy between lines tended to disappear after 8 weeks of age. In conclusion, this study showed that MRT in the proventriculus-gizzard system was a major factor associated with genotype differences between the D+ and D- genetic chicken lines selected for divergent digestion efficiency, with longer MRT found in D+ than in D- birds.
    animal 11/2010; 4(11):1861-72. DOI:10.1017/S1751731110001266 · 1.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Rome criteria have been introduced to create order in the heterogeneity of functional dyspepsia. The applicability of these symptom-based classification systems remains controversial. To evaluate the successive Rome criteria for functional dyspepsia in a large pool of patients with endoscopically verified functional dyspepsia. Patients referred to a secondary care district hospital were asked to fill out a questionnaire on gastrointestinal symptoms 2 weeks before upper gastrointestinal endoscopy. Patients were classified according to the Rome I, II, and III criteria for functional dyspepsia. Nine hundred and twelve (70%) patients had no organic disorder explaining their symptoms. According to the Rome I, II, and III criteria, 371 (41%), 735 (81%), and 551 (60%) of these patients had functional dyspepsia, respectively. Twenty-five percent of patients had functional dyspepsia according to all 3 Rome criteria, whereas 15% was not classifiable at all. Forty-four percent and 42% of the patients, respectively, had epigastric pain syndrome and postprandial distress syndrome according to the Rome III criteria; however, 26% of all patients met both criteria and 40% was not classified at all. The symptom-based Rome classification of functional dyspepsia does not lead to an easily applicable and consistent system that is useful in clinical practice or scientific research.
    Journal of clinical gastroenterology 09/2008; 43(2):118-22. DOI:10.1097/MCG.0b013e31815591f7 · 3.19 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The pathogenesis and pathophysiology of irritable bowel syndrome is complex and still incompletely known. Potential pathogenetic factors include genes, infectious events, psychological symptoms and other loosely defined environmental factors. Both alterations at the central and peripheral level are thought to contribute to the symptoms of irritable bowel syndrome, including psychosocial factors, abnormal gastrointestinal motility and secretion, and visceral hypersensitivity. Today irritable bowel syndrome is viewed upon as a disorder of dysregulation of the so-called brain-gut axis, involving abnormal function in the enteric, autonomic and/or central nervous systems, with peripheral abnormalities probably dominating in some patients and disturbed central processing of signals from the periphery in others. Lines of evidence also suggest that inflammation within the gastrointestinal tract may be of great importance in at least subgroups of irritable bowel syndrome patients. To conclude, a complex picture of the pathogenesis and pathophysiology of irritable bowel syndrome is emerging, with interactions between several different alterations resulting in the divergent symptom pattern in these patients.
    Digestive and Liver Disease 04/2007; 39(3):201-15. DOI:10.1016/j.dld.2006.10.014 · 2.89 Impact Factor